<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Saudi Med</journal-id>
      <journal-id journal-id-type="publisher-id">ASM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Saudi Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0256-4947</issn>
      <issn pub-type="epub">0975-4466</issn>
      <publisher>
        <publisher-name>Medknow Publications</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">19448374</article-id>
      <article-id pub-id-type="pmc">2813656</article-id>
      <article-id pub-id-type="publisher-id">ASM-29-234</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>What's Your Diagnosis?</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A 74-year-old woman with a 1-month history of itching and skin rash</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ghosh</surname>
            <given-names>Sujoy</given-names>
          </name>
          <xref ref-type="corresp" rid="cor1"/>
          <xref ref-type="aff" rid="AF0001"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ghosh</surname>
            <given-names>Arjun K.</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Collier</surname>
            <given-names>Andrew</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001"/>
        </contrib>
      </contrib-group>
      <aff id="AF0001">From The Ayr Hospital General Medicine, Ayr, United Kingdom</aff>
      <author-notes>
        <corresp id="cor1">Correspondence: Dr. Sujoy Ghosh &#xB7; The Ayr Hospital General Medicine Dalmellington Road Ayr, KA6 6DX United Kingdom &#xB7; T: +44-1292-610-555 F: +44-1292-614-538 &#xB7; <email xlink:href="drsujoyghosh@rediffmail.com">drsujoyghosh@rediffmail.com</email> &#xB7; Accepted for publication April 2009</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2009</year>
      </pub-date>
      <volume>29</volume>
      <issue>3</issue>
      <fpage>234</fpage>
      <lpage>234</lpage>
      <permissions>
        <copyright-statement>&#xA9; Annals of Saudi Medicine</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>A 74-year-old woman presented with a 1-month history of itching followed by a rash. The bullous lesions were large and wide-spread (including lesions on the arm, legs and torso, covering almost 20% of the body surface) (<xref ref-type="fig" rid="F0001">Figure 1</xref>). Many lesions were de-roofed and there was evidence of underlying inflammation and the presence of marginal vesiculation. She was hypothyroid (taking levothyroxine) and hypertensive (taking bendroflumethiazide) and had a history of a cerebrovascular accident for which she was taking aspirin. She had a fracture of the shaft of the left femur 3 weeks prior to presentation. She was pale with hemoglobin of 8.1 g/dL with normal renal and hepatic function.</p>
    <fig id="F0001" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Multiple lesions in different stages of evolution.</p>
      </caption>
      <graphic xlink:href="ASM-29-234-g001"/>
    </fig>
    <p>What is your diagnosis?</p>
    <p>FOR THE ANSWER, VISIT:</p>
    <p>
      <ext-link ext-link-type="uri" xlink:href="http://www.saudiannals.net">http://www.saudiannals.net</ext-link>
    </p>
    <sec id="sec1-1">
      <title>Diagnosis: Bullous Pemphigoid</title>
      <p>This patient presented with bullous lesions that were large, blistering and itchy, and that sub-sequently underwent excoriation. There was evidence of underlying inflammation and a skin biopsy showed subepidermal blister with adjacent excoriation. There was some evidence of inflammatory cell infiltrate in the floor and a few eosinophils. Immunofluorescence studies showed strong IgG and C3 positivity at the dermo-epidermal junction (Figure <xref ref-type="fig" rid="F0002">2</xref>, <xref ref-type="fig" rid="F0003">3</xref>), which was diagnostic of bullous pemphigoid. She was treated with oral steroids (prednisolone, initially 70 mg/day) and topical mupirocin and doing well after one year.</p>
      <fig id="F0002" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Immunofluorescence study showing IgG positivity at the dermo-epidermal junction</p>
        </caption>
        <graphic xlink:href="ASM-29-234-g002"/>
      </fig>
      <fig id="F0003" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Immunofluorescence study showing C3 positivity at the dermo-epidermal junction</p>
        </caption>
        <graphic xlink:href="ASM-29-234-g003"/>
      </fig>
    </sec>
    <sec sec-type="" id="sec1-2">
      <title>DISCUSSION</title>
      <p>Bullous pemphigoid (BP) is a common autoimmune blistering disease with an annual incidence of 6.1 to 7 per million.<xref ref-type="bibr" rid="CIT1">1</xref> It is almost twice as common in men as compared to women.<xref ref-type="bibr" rid="CIT2">2</xref> The disease is usually self-limitiing, but may last from days to months and rarely even up to ten years.<xref ref-type="bibr" rid="CIT3">3</xref> The co-existence of other autoimmune disease is not uncommon.<xref ref-type="bibr" rid="CIT4">4</xref> The clinical hallmark of BP is the presence of widespread tense bullae, which may arise from normal (non-inflamed bullae) or erythematous (inflammatory bullae). They can occur anywhere, but there is a predilection for the groin, lower abdomen and the flexural surface of limbs.<xref ref-type="bibr" rid="CIT5">5</xref></p>
      <p>Many clinical variants have been described based on positive immunofluorescence studies.<xref ref-type="bibr" rid="CIT6">6</xref> Several drugs have been implicated in precipitating a clinical heterogeneous group of bullous disorders similar to BP.<xref ref-type="bibr" rid="CIT7">7</xref> Other differential diagnoses include IgA bullous dermatosis, bullous systemic lupus erythematosus, epidermolysis bullous acquista and pemphigoid. Clinical, histological and immunopathological techniques are used to confirm the diagnosis, including direct immunoflourescence for IgG, IgM, IgA and C3. The biopsy site should preferably be from the upper body and perilesional. Direct immune electron microscopy is the gold standard for antibody localization within the basement membrane zone.<xref ref-type="bibr" rid="CIT8">8</xref></p>
      <p>BP is generally regarded as a benign, self-limited disease. Exacerbations and remissions are common and tend to be milder than the initial episode.<xref ref-type="bibr" rid="CIT9">9</xref> The mortality rate averages approximately 27%.<xref ref-type="bibr" rid="CIT10">10</xref> Most patients affected by BP are elderly, having multiple co-morbidities and infection, and co-morbidities usually account for mortality. Localized disease is generally self-limited and responds to potent topical corticosteroids.<xref ref-type="bibr" rid="CIT11">11</xref> For more widespread disease systemic steroids have been used, both oral and high-dose, pulsed intravenous corticosteroids.<xref ref-type="bibr" rid="CIT12">12</xref> Several studies suggest that antibacterial agents like erythromycin, minocycline or dapsone may control disease activity. In addition, other immunosuppressives like azathioprine, methotrexate, leflunomide or mycophenolate mofetil may have some role in management, especially as an adjuvant to corticosteroid therapy. In a small number of cases intravenous immunoglobulins have been used with variable success.<xref ref-type="bibr" rid="CIT13">13</xref></p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="CIT1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bernard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vaillant</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Labeille</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bedane</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Arbeille</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Denoeux</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group</article-title>
          <source>Arch Dermatol</source>
          <year>1995</year>
          <volume>131</volume>
          <issue>1</issue>
          <fpage>48</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">7826096</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jung</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kippes</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Messer</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zillikens</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rzany</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1999</year>
          <volume>41</volume>
          <fpage>266</fpage>
          <lpage>268</lpage>
          <comment>(2 Pt 1)</comment>
          <pub-id pub-id-type="pmid">10426901</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Venning</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Wojnarowska</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Lack of predictive factors for the clinical course of bullous pemphigoid</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1992</year>
          <volume>26</volume>
          <issue>4</issue>
          <fpage>585</fpage>
          <lpage>589</lpage>
          <pub-id pub-id-type="pmid">1597545</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Venning</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Wojnarowska</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Welch</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Bullous pemphigoid and autoimmunity</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1993</year>
          <volume>29</volume>
          <fpage>181</fpage>
          <lpage>184</lpage>
          <comment>(2 Pt 1)</comment>
          <pub-id pub-id-type="pmid">8335735</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Korman</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Bullous pemphigoid. The latest in diagnosis, prognosis, and therapy</article-title>
          <source>Arch Dermatol</source>
          <year>1998</year>
          <volume>134</volume>
          <issue>9</issue>
          <fpage>1137</fpage>
          <lpage>1141</lpage>
          <pub-id pub-id-type="pmid">9762028</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>HN</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>WP</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>RS</given-names>
              <suffix>III</suffix>
            </name>
          </person-group>
          <article-title>Clinical variants of pemphigoid</article-title>
          <source>Int J Dermatol</source>
          <year>1986</year>
          <volume>25</volume>
          <issue>1</issue>
          <fpage>17</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">3512459</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruocco</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sacerdoti</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Pemphigus and bullous pemphigoid due to drugs</article-title>
          <source>Int J Dermatol</source>
          <year>1991</year>
          <volume>30</volume>
          <issue>5</issue>
          <fpage>307</fpage>
          <lpage>312</lpage>
          <pub-id pub-id-type="pmid">1829722</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kirtschig</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wojnarowska</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune blistering diseases: an up-date of diagnostic methods and investigations</article-title>
          <source>Clin Exp Dermatol</source>
          <year>1994</year>
          <volume>19</volume>
          <issue>2</issue>
          <fpage>97</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="pmid">8050161</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wojnarowska</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kirtschig</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Highet</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Venning</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Khumalo</surname>
              <given-names>NP</given-names>
            </name>
          </person-group>
          <article-title>Guidelines for the management of bullous pemphigoid</article-title>
          <source>Br J Dermatol</source>
          <year>2002</year>
          <volume>147</volume>
          <issue>2</issue>
          <fpage>214</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="pmid">12174090</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roujeau</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Lok</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bastuji-Garin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mhalla</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Enginger</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bernard</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>High risk of death in elderly patients with extensive bullous pemphigoid</article-title>
          <source>Arch Dermatol</source>
          <year>1998</year>
          <volume>134</volume>
          <issue>4</issue>
          <fpage>465</fpage>
          <lpage>469</lpage>
          <pub-id pub-id-type="pmid">9554299</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borradori</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Prost</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wolkenstein</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bernard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Baccard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morel</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Localized pretibial pempphigoid and pemphigoid nodularis</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1992</year>
          <volume>27</volume>
          <fpage>863</fpage>
          <lpage>867</lpage>
          <comment>(5 Pt 2)</comment>
          <pub-id pub-id-type="pmid">1469147</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siegel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Eaglstein</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>High-dose methylprednisolone in the treatment of bullous pemphigoid</article-title>
          <source>Arch Dermatol</source>
          <year>1984</year>
          <volume>120</volume>
          <issue>9</issue>
          <fpage>1157</fpage>
          <lpage>1165</lpage>
          <pub-id pub-id-type="pmid">6383221</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fine</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Management of acquired bullous skin diseases</article-title>
          <source>N Engl J Med</source>
          <year>1995</year>
          <volume>333</volume>
          <issue>22</issue>
          <fpage>1475</fpage>
          <lpage>1484</lpage>
          <pub-id pub-id-type="pmid">7477149</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
